In 1999 the National Disease Surveillance Centre was asked to evaluate the problem of antimicrobial resistance, including MRSA, in Ireland and to formulate a strategy for the future. It gave detailed consideration to these issues and drew up a strategy for the control of the resistance in Ireland, which was launched on 19 June 2001. This report contains a wide range of detailed recommendations to address the issue, including a strategy to control the inappropriate use of antibiotics.
Approximately €16 million in funding has been made available to date, of which €4.5 million was provided this year to health boards to implement the strategy.
A national committee comprised of a wide range of experts was established in 2002 to develop guidelines, protocols and strategies in regard to antimicrobial resistance. As part of its remit it provides advice to the regional SARI committees in each health board area which were established as a result of the strategy's recommendations. Tackling this problem is a multi-faceted issue which will require action on a number of fronts. Implementation of the strategy is taking place on a phased basis.
Since 1 January this year, MRSA bacteraemia is included in the revised list of notifiable diseases of the infectious diseases regulations so hospitals are now legally required to report an incidence of the infection.